Application 040860

Type: ANDA
Sponsor: INGENUS PHARMS NJ

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE	ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE	TABLET;ORAL	325MG;200MG;16MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A040860-001	CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE	ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE	325MG;200MG;16MG	TABLET / ORAL			2010-01-07

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 44 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2022-10-28 04:53 UTC	2022-10	A040860-001	CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE	325MG;200MG;16MG	TABLET / ORAL		2010-01-07	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A040860-001	CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE	325MG;200MG;16MG	TABLET / ORAL		2010-01-07	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A040860-001	CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE	325MG;200MG;16MG	TABLET / ORAL	RS	2010-01-07	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A040860-001	CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE	325MG;200MG;16MG	TABLET / ORAL		2010-01-07	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A040860-001	AB	1	`74a2ff9319b5…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040860-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040860-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040860-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040860-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040860-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040860-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040860-001	AB	1	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 5 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
50742-256	CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE	carisoprodol, aspirin and codeine phosphate	Ingenus Pharmaceuticals, LLC	ANDA	Current
50742-256	CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE	carisoprodol, aspirin and codeine phosphate	Ingenus Pharmaceuticals, LLC	ANDA	Current
50742-256	Carisoprodol, Aspirin and Codeine Phosphate	Carisoprodol, Aspirin and Codeine Phosphate	Ingenus Pharmaceuticals, LLC	ANDA	Current
50742-256	Carisoprodol, Aspirin and Codeine Phosphate	Carisoprodol, Aspirin and Codeine Phosphate	Ingenus Pharmaceuticals, LLC	ANDA	Current
64980-176	Carisoprodol, Aspirin and Codeine Phosphate	Carisoprodol, Aspirin and Codeine Phosphate	Rising Pharmaceuticals, Inc.	ANDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
76075	ORIG	2023-11-02